A National Survey of Marijuana Use Among U.S. Adults According to Obesity Status, 2016-2022.

IF 3.1 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Ray M Merrill
{"title":"A National Survey of Marijuana Use Among U.S. Adults According to Obesity Status, 2016-2022.","authors":"Ray M Merrill","doi":"10.1089/can.2024.0069","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background and Objective:</b> Research has linked marijuana use with lower body mass index (BMI). The current study explores the correlation between marijuana use on BMI in the general U.S. population. It reports the prevalence of marijuana in adults in relation to BMI, overall and across the levels of important variables. <b>Materials and Methods:</b> This study used a probability sample of U.S. adults 18 years of age and older from the 2016 through 2022 Behavioral Risk Factor Surveillance System, a telephone-administered survey. The survey collects data from a representative sample regarding health-related risk behaviors, chronic health conditions, and use of preventive services. The primary outcome variables are current (at least once in the last 30 days) and daily (at least 20 of the last 30 days) marijuana use. <b>Results:</b> The study sample consists of 735,921 participants in the surveys that completed the optional module on marijuana use. Prevalence of marijuana use in adults doubled during the study period (7.48% to 14.91%). The increase directly corresponds with a shift toward legalization of medical and recreational marijuana. On average, the prevalence of use is 9% higher when medical marijuana is legal and 81% higher when recreational marijuana is legal (vs. not legal). For obese individuals, prevalence of current marijuana use is 35% lower than for nonobese individuals on average. Lower prevalence of marijuana use in obese individuals is consistently observed across the levels of certain demographic variables, employment status, tobacco smoking history, marijuana legalization status, and certain medical conditions (asthma, arthritis, and depression). In 2022, the adjusted odds of current or daily marijuana use are significantly lower and similar among obese (vs. non-obese) (0.68, 0.69, respectively), such that reduced obesity does not require daily use. Similarly, the adjusted odds of current marijuana use decrease in similar fashion to daily marijuana use with higher BMI weight classification. <b>Conclusion:</b> Marijuana use is correlated with lower BMI. As legalization and prevalence of the drug in the U.S. increases, the prevalence of obesity may decline. However, clinicians should view this outcome along with the known health risks associated with marijuana use.</p>","PeriodicalId":9386,"journal":{"name":"Cannabis and Cannabinoid Research","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cannabis and Cannabinoid Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/can.2024.0069","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Objective: Research has linked marijuana use with lower body mass index (BMI). The current study explores the correlation between marijuana use on BMI in the general U.S. population. It reports the prevalence of marijuana in adults in relation to BMI, overall and across the levels of important variables. Materials and Methods: This study used a probability sample of U.S. adults 18 years of age and older from the 2016 through 2022 Behavioral Risk Factor Surveillance System, a telephone-administered survey. The survey collects data from a representative sample regarding health-related risk behaviors, chronic health conditions, and use of preventive services. The primary outcome variables are current (at least once in the last 30 days) and daily (at least 20 of the last 30 days) marijuana use. Results: The study sample consists of 735,921 participants in the surveys that completed the optional module on marijuana use. Prevalence of marijuana use in adults doubled during the study period (7.48% to 14.91%). The increase directly corresponds with a shift toward legalization of medical and recreational marijuana. On average, the prevalence of use is 9% higher when medical marijuana is legal and 81% higher when recreational marijuana is legal (vs. not legal). For obese individuals, prevalence of current marijuana use is 35% lower than for nonobese individuals on average. Lower prevalence of marijuana use in obese individuals is consistently observed across the levels of certain demographic variables, employment status, tobacco smoking history, marijuana legalization status, and certain medical conditions (asthma, arthritis, and depression). In 2022, the adjusted odds of current or daily marijuana use are significantly lower and similar among obese (vs. non-obese) (0.68, 0.69, respectively), such that reduced obesity does not require daily use. Similarly, the adjusted odds of current marijuana use decrease in similar fashion to daily marijuana use with higher BMI weight classification. Conclusion: Marijuana use is correlated with lower BMI. As legalization and prevalence of the drug in the U.S. increases, the prevalence of obesity may decline. However, clinicians should view this outcome along with the known health risks associated with marijuana use.

2016-2022 年根据肥胖状况对美国成年人使用大麻情况进行的全国调查。
背景和目的:研究表明,吸食大麻与较低的体重指数(BMI)有关。本研究探讨了美国普通人群吸食大麻与体重指数之间的相关性。它报告了成年人吸食大麻的流行率与体重指数的关系,包括总体情况和各种重要变量的水平。材料和方法:本研究使用了 2016 年至 2022 年行为风险因素监测系统中 18 岁及以上美国成年人的概率样本,这是一项电话调查。该调查从具有代表性的样本中收集有关健康相关风险行为、慢性健康状况和预防服务使用情况的数据。主要结果变量是当前(过去 30 天内至少一次)和日常(过去 30 天内至少 20 天)使用大麻的情况。研究结果研究样本包括 735,921 名完成了大麻使用情况可选模块的调查参与者。在研究期间,成年人吸食大麻的流行率翻了一番(从 7.48% 上升到 14.91%)。这一增长与医用和娱乐用大麻合法化的转变直接吻合。平均而言,当医用大麻合法时,使用率要高出 9%,当娱乐用大麻合法时(与不合法时相比),使用率要高出 81%。对于肥胖者来说,当前使用大麻的流行率比非肥胖者平均低 35%。在某些人口统计学变量、就业状况、吸烟史、大麻合法化状况和某些病症(哮喘、关节炎和抑郁症)的不同水平上,都能持续观察到肥胖者使用大麻的流行率较低。2022 年,肥胖者(与非肥胖者相比)当前或每天吸食大麻的调整后几率明显较低且相似(分别为 0.68 和 0.69),因此减少肥胖并不需要每天吸食大麻。同样,BMI 体重分类越高,当前吸食大麻的调整后几率下降的方式与每日吸食大麻相似。结论:吸食大麻与较低的体重指数相关。随着大麻在美国的合法化和普及率的提高,肥胖症的发病率可能会下降。不过,临床医生在看待这一结果的同时,也应考虑到吸食大麻带来的已知健康风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cannabis and Cannabinoid Research
Cannabis and Cannabinoid Research PHARMACOLOGY & PHARMACY-
CiteScore
6.80
自引率
7.90%
发文量
164
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信